ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?
作者信息
Tsilimigras Diamantis I, Paredes Anghela Z, Pawlik Timothy M
机构信息
Department of Surgery, Division of Surgical Oncology, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
出版信息
Ann Surg Oncol. 2020 Dec;27(13):5233-5234. doi: 10.1245/s10434-020-08697-y. Epub 2020 Jun 26.
PMID:32591955
Abstract
摘要
相似文献
1
ASO Author Reflections: Identification of Intrahepatic Cholangiocarcinoma Clusters Using Machine Learning Techniques: Should Patients be Treated Differently?ASO作者反思：使用机器学习技术识别肝内胆管癌簇：患者是否应接受不同的治疗？
Ann Surg Oncol. 2020 Dec;27(13):5233-5234. doi: 10.1245/s10434-020-08697-y. Epub 2020 Jun 26.
2
ASO Author Reflections: Use of Machine Learning to Predict Early Recurrence After Resection of Intrahepatic Cholangiocarcinoma.ASO作者反思：利用机器学习预测肝内胆管癌切除术后早期复发
Ann Surg Oncol. 2023 Sep;30(9):5416-5417. doi: 10.1245/s10434-023-13672-4. Epub 2023 May 24.
3
ASO Author Reflections: Long-Term Outcomes and Optimal Margin Width Among Patients Undergoing Hepatectomy for Intrahepatic Cholangiocarcinoma.ASO作者反思：肝内胆管癌肝切除患者的长期预后和最佳切缘宽度
Ann Surg Oncol. 2023 Jul;30(7):4302-4303. doi: 10.1245/s10434-023-13351-4. Epub 2023 Mar 24.
4
ASO Author Reflections: Intrahepatic Cholangiocarcinoma: Downstaging Strategies Open the Gate to Surgery and Cure.ASO作者反思：肝内胆管癌：降期策略为手术和治愈打开大门。
Ann Surg Oncol. 2020 Oct;27(10):3738-3739. doi: 10.1245/s10434-020-08489-4. Epub 2020 Apr 20.
5
ASO Author Reflections: Incorporating Circulating Tumor DNA in Perioperative Management of Intrahepatic Cholangiocarcinoma.ASO作者反思：将循环肿瘤DNA纳入肝内胆管癌围手术期管理
Ann Surg Oncol. 2023 Jun;30(6):3864-3865. doi: 10.1245/s10434-023-13211-1. Epub 2023 Feb 8.
6
ASO Author Reflections: Disparate Outcomes in Stage II Intrahepatic Cholangiocarcinoma: A Case for Upstaging Multifocal Tumors.ASO作者反思：II期肝内胆管癌的不同结局——多灶性肿瘤上调分期的案例
Ann Surg Oncol. 2022 Aug;29(8):5103-5104. doi: 10.1245/s10434-022-11824-6. Epub 2022 Apr 28.
7
ASO Author Reflections: Accuracy of Preoperative Staging and Downstaging After Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma.ASO作者反思：可切除性肝内胆管癌新辅助治疗后术前分期及降期的准确性
Ann Surg Oncol. 2023 Aug;30(8):4809-4810. doi: 10.1245/s10434-023-13485-5. Epub 2023 Apr 12.
8
ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma.ASO作者反思：更高的肿瘤负荷状态决定了手术切缘状态对肝内胆管癌患者的影响。
Ann Surg Oncol. 2023 Apr;30(4):2033-2034. doi: 10.1245/s10434-022-12824-2. Epub 2022 Nov 17.
9
ASO Author Reflections: A New Reliable Method of Evaluating Cancer-Associated Fibroblasts in Resected Specimen of Intrahepatic Cholangiocarcinoma.ASO作者反思：一种评估肝内胆管癌切除标本中癌症相关成纤维细胞的新可靠方法。
Ann Surg Oncol. 2023 Sep;30(9):5429-5430. doi: 10.1245/s10434-023-13671-5. Epub 2023 Jun 5.
10
ASO Author Reflections: Monitoring the Risk of Recurrence After Curative-Intent Liver Resection for Intrahepatic Cholangiocarcinoma by Applying Hazard Function Analysis.ASO作者反思：应用风险函数分析监测肝内胆管癌根治性肝切除术后的复发风险
Ann Surg Oncol. 2023 Mar;30(3):1350-1351. doi: 10.1245/s10434-022-12469-1. Epub 2022 Aug 25.
引用本文的文献
1
Artificial intelligence and cholangiocarcinoma: Updates and prospects.人工智能与胆管癌：最新进展与前景
World J Clin Oncol. 2022 Feb 24;13(2):125-134. doi: 10.5306/wjco.v13.i2.125.
Zotero 插件